According to the report, the global fluorine-18 market was valued over US$ 1.5 Bn in 2020 and is projected to expand at a CAGR of 7.5% from 2021 to 2031.
According to the report, the global fluorine-18 market was valued over US$ 1.5 Bn in 2020 and is projected to expand at a CAGR of 7.5% from 2021 to 2031. Fluorine-18 is the most important radionuclide used in positron emission tomography (PET) today, largely due to its unique physical and nuclear characteristics. Agents such as the clinical oncology tracer FDG, the most widely used PET-radiopharmaceutical, have driven interest toward the chemistry of radiopharmaceuticals utilizing fluorine-18.
Rise in Preference for PET/CT and PET Scans to Drive Global Market
PET/CT and PET are modern systems used to detect and treat cancer, cardiovascular diseases, and other neurology related diseases. Molecular imaging with novel radiopharmaceuticals has been engineered to target specific subcellular processes and improve diagnostic accuracy using radioactive molecule as a tracer in PET/CT scan. Hence, the preference for PET/CT scan is rising, which is anticipated to drive the global fluorine-18 market.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=82266
Lack of Availability and High Operating Expenses to Hamper Global Market
The limitations of FDG-PET are its lack of availability and high operating expenses. F-18 fluoride ion is created in a cyclotron, and then converted via an automated chemistry module into the F-18 FDG. The cost of establishing the PET/CT scan facility with cyclotron is around US$ 5 Mn to US$ 6 Mn.
FDG to Dominate Global Market
The global fluorine-18 market has been segmented based on product and end user. In terms of product, the global fluorine-18 market has been classified into FDG, NaF, and others. The FDG segment is expected to account for a major share of the global market by 2031, due to the increase in demand for PET/CT scan in oncology.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=82266
Hospitals to be Major End User
In terms of end user, the global fluorine-18 market has been divided into hospitals, diagnostic centers, and others. The hospitals segment is likely to expand at a high CAGR during the forecast period, due to the increase in the demand for the installation of new PET-CT machines in the upcoming hospital projects across the globe, which drive the demand for F-18 isotopes.
North America to Dominate Global Market
The global fluorine-18 market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global fluorine-18 market in 2020, followed by Europe. The fluorine-18 market in Asia Pacific is projected to expand at a high CAGR from 2021 to 2031. Product launches, acquisitions, distribution agreements, alliances, and geographical expansion by local players, especially in China and India, are anticipated to drive the fluorine-18 market in the region.
Buy Fluorine-18 Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=82266<ype=S
Competition Landscape
The report also presents profiles of leading players in the global fluorine-18 market. These include Lantheus Holdings, Inc., Siemens Healthineers, Advanced Accelerator Applications (a Novartis AG Company), GE Healthcare (General Electric Company), Blue Earth Diagnostics (A Bracco Imaging Company), Jubilant Pharma Limited, China lsotope & Radiation Corporation, Eli Lilly and Company, Curium Pharma, and Yantai Dongcheng Pharmaceutical Group Co., Ltd.
The leading companies in the global fluorine-18 market focus on strengthening the distribution network and expanding product range to gain market share. For instance, in February 2018, Advanced Accelerator Applications signed an exclusive license agreement with the Cancer Targeted Technology to develop CTT1057, an F-18 labeled PSMA ligand for diagnostic applications in prostate cancer.
Browse More Trending Reports by Transparency Market Research:
Stem Cell Gun Devices Market: https://www.transparencymarketresearch.com/stem-cell-gun-devices-market.html
Revascularization Devices Market: https://www.transparencymarketresearch.com/revascularization-devices-market.html
Anesthesia Disposables Market: https://www.transparencymarketresearch.com/anesthesia-disposables-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/